Home › Funds › Foyston, Gordon & Payne Inc › MDLZ

Foyston, Gordon & Payne Inc position in MDLZ

MONDELEZ INTL INC · Consumer Staples

Foyston, Gordon & Payne Inc reported holding 133,803 shares of MDLZ (MONDELEZ INTL INC) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 1.55% of its reported portfolio and ranking #25 among its reported holdings. Foyston, Gordon & Payne Inc has disclosed MDLZ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)133.80K sh
Reported value held$7.74M
Portfolio Weight1.55%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Foyston, Gordon & Payne Inc's MDLZ position evolved

Foyston, Gordon & Payne Inc first disclosed a stake in MDLZ in Q3 2023 at 135,671 shares (US$9.4M). The position peaked in Q4 2023 at 136,904 shares, worth US$9.9M. Across 13 filings, Foyston, Gordon & Payne Inc increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 133,803 shares valued at US$7.7M — a reduction of -22,836 shares quarter over quarter.. Notable position changes include a 25% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 135.67K $9.42M New
Q4 2023 136.90K $9.92M Add
Q1 2024 135.18K $9.46M Reduce
Q2 2024 134.01K $8.77M Reduce
Q3 2024 114.21K $8.41M Reduce
Q4 2024 114.56K $6.84M Hold
Q1 2025 114.65K $7.78M Hold
Q2 2025 115.50K $7.79M Add
Q3 2025 113.40K $7.08M Reduce
Q4 2025 136.62K $7.35M Add
Q1 2026 171.35K $9.88M Add
Q2 2026 156.64K $9.18M Reduce
Q3 2026 133.80K $7.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDLZ and 13F data

MDLZ (MONDELEZ INTL INC) is a Consumer Staples company. 21 other funds we track also report a position in MDLZ — the largest reported positions include Capital Research Global Investors (US$4.03B), Capital Research Global Investors (US$3.66B), JPMorgan Chase & Co (US$3.50B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDLZ

All MDLZ fund holders →

FAQ

How long has Foyston, Gordon & Payne Inc held MDLZ?

Foyston, Gordon & Payne Inc has disclosed MDLZ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Foyston, Gordon & Payne Inc's current position in MDLZ?

As of Q3 2026, Foyston, Gordon & Payne Inc holds 133.80K shares of MDLZ (MONDELEZ INTL INC), valued at $7.74M, representing 1.55% of its reported portfolio and ranking #25.

Has Foyston, Gordon & Payne Inc been buying or selling MDLZ?

In the latest 13F filing (Q3 2026), Foyston, Gordon & Payne Inc reduced its position in MDLZ. The position peaked in Q4 2023 at 136.90K shares.

Which other funds hold MDLZ?

Other major institutional holders of MDLZ include Capital Research Global Investors, Capital Research Global Investors, JPMorgan Chase & Co, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.